Skip to main content

Table 1 Patients’ demographic and perioperative data

From: Impeding factors of early rehabilitation postoperatively after rheumatoid toe arthroplasty: a single-center retrospective cohort study

Variables

Possible group

Impossible group

P value

N

191

109

 

Age (years)

63.7 (10.6)

62.1 (10.1)

0.20

Male/female

14/177

4/105

0.20

Height (cm)

155.2 (7.2)

156.1 (7.2)

0.30

Weight (kg)

51.3 (9.0)

51.3 (8.6)

0.99

Medications

   

 Daily prednisolone medication, n (%)

81 (42.4%)

36 (33.0)

0.11

 Daily prednisolone dose (mg)

0 [0–2.75]

0 [0–2.25]

0.22

 Number of DMARDs taken by patients

1 [1–2]

1 [1–2]

0.37

Duration of surgery (min)

102.2 (37.4)

109.6 (34.1)

0.09

 Number of operated toes

   

Duration of anesthesia (min)

154.4 (42.3)

162.3 (39.5)

0.11

Intraoperative fluid volume (ml)

918.4 (306.6)

1000.5 (329.5)

0.03

Blood loss (g)

2.3 (5.3)

3.9 (8.0)

0.03

Anesthesia methods

   

 General anesthesia, n (%)

160 (83.8%)

89 (81.7%)

0.64

 Regional anesthesia, n (%)

105 (55.0%)

47 (43.1%)

0.05

 Epidural anesthesia, n (%)

28 (14.7%)

21 (19.3%)

0.30

 Spinal anesthesia, n (%)

31 (16.3%)

20 (18.3%)

0.64

 Peripheral nerve block, n (%)

58 (30.1%)

13 (11.9%)

< 0.001

Intraoperative fentanyl dose (μg)

250 [0–400]

300 [50–400]

0.14

Postoperative fentanyl use, n (%)

75 (39.3%)

57 (52.3%)

0.03

Incidence of PONV before rehabilitation, n (%)

42 (22.0%)

47 (43.1%)

< 0.001

Number of rescue analgesics administered before rehabilitation

1 [0–1]

1 [0–2]

0.01

Days from surgery to discharge

14.7 (0.4)

14.7 (0.6)

0.94

  1. Data are presented as mean (SD), median [interquartile range], or number (%)
  2. DMARDs disease-modifying anti-rheumatic drugs, PONV postoperative nausea and vomiting